Root Canal Treatment With TotalFill® Bioceramic Sealer and AH Plus® Sealer

July 13, 2023 updated by: National University Hospital, Singapore

Clinical Outcome of Root Canal Treatment With TotalFill® Bioceramic Sealer and AH Plus® Sealer: A Randomized Controlled Trial

The study design is a double blinded randomized controlled trial and 170 subjects (teeth) , 85 in each of the 2 groups, will be enrolled from the patients at the NUH dental centre endodontic unit. The study aims to assess how the use of TotalFill® bioceramic sealer affects the healing outcome of apical periodontitis compared to a control AH plus®.

Conventional root canal treatment will be done during this study. Radiographs will be taken at each study visit during the study for root canal. The preoperative, postoperative and review clinical and radiographic data will be analysed.

Study Overview

Detailed Description

Randomization and Blinding Study subject (tooth) will be randomized in a 1:1 allocation ratio between the two treatment groups. Allocation will be by random permuted block and stratified by gender to enhance balance. Computer generated randomized allocation for each subject will be concealed in opaque envelope. The envelope will only be opened by the operator on the obturation visit of the enrolled patient and the randomization number assigned to them.

In the event that a patient has more than 1 tooth eligible for the study, only one tooth on left and/or right side of the mouth will be recruited for the study. Therefore, a patient could contribute a maximum of two teeth for this study (i.e. a maximum of one tooth on each side of the mouth). Selection of tooth will be done using computer generated randomization number.

Study Visits and Procedures After cleaning and shaping and the patients are deemed ready for obturation, the patients will be randomly assigned to one of the 2 groups for obturation using AH plus® or TotalFill® bioceramic sealer.

  • The patients and the examiners will be blinded to the type of sealer used but it would not be possible to blind the operators.

    b. Post Study Follow up and Procedures

  • A follow up phone call will be made to collect the patient pain experience on day 1, day 3 and day 7 post treatment which they have recorded on their pain/discomfort diary.
  • At the 6-month and 12-month review, patients will be examined for any clinical signs and symptoms and a review radiograph will be taken to assess the size of the periapical lesion.

    c. Radiographic assessment

  • All radiographs will be taken with a localising device to control for angulation and magnification.
  • Calibrated measurement tools in the dental practice management software will be used to measure the diameter of the lesion across the longest diameter.

Statistical and Analytical Plans

a. General Considerations Intention-to-treat population is considered the main analysis population. The intention-to-treat population includes all subjects who were assigned a randomization number. Study subject's demographic and pre-operative characteristics will be summarized for each treatment group.

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 119074
        • National University Hospital, Singapore

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 95 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • A preoperative periapical radiograph will be required for diagnosis.
  • Subjects at least 21 years old.
  • Medically healthy
  • In a patient with multiple teeth requiring root canal treatment, only 1 tooth from each side will be included and selected at random.

Exclusion Criteria:

  • Patient below 21 years old
  • Pregnant women.
  • Patients with autoimmune diseases and uncontrolled diabetes.
  • Teeth with periodontal probing depths of 5mm or more.
  • Incomplete root formation that is detected radiographically.
  • Cracked teeth
  • Teeth are deemed to have poor restorative prognosis.
  • Teeth with adjacent teeth on the same side that require root canal treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TotalFill® Bioceramic sealer
It will be used in conjunction with TotalFill® bioceramic impregnated gutta percha points for the obturation of root canals. It is dispensed through a fine disposable syringe into the root canals during obturation.
The participant will be treated with TotalFill® Bioceramic sealer.
Active Comparator: AH plus® sealer
It consists of 2 pastes that are mixed together in equal amounts before it is used in conjunction with gutta percha points for obturation during root canal treatment.
The participant will be treated with AH plus® sealer.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the status of periapical lesion size
Time Frame: comparison of the periapical lesion size at baseline, 6 month and 12 month
Proportion z-test will be carried to compare the proportion of study subjects with improved apical lesion size between the two treatment groups. Odds ratio with 95% confidence interval will be reported. Logistic regression analysis adjusted for the stratification variables (gender) and other confounding factors (namely patency, extrusion of sealer or GP, short fill, voids, pre-op apical size, pre-op clinical symptoms and number of C&S visits).
comparison of the periapical lesion size at baseline, 6 month and 12 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of the pain score of post-op pain
Time Frame: Day 1, Day 3 and Day 7 post treatment
Proportion z-test will be carried out. The odds ratio with a 95% confidence interval will be reported. A two-sample t-test will be performed to access the change in pain score (Pain was recorded as "no pain" (score = 0) or a 5-point Likert scale ranging from very mild pain (score = 1) to severe pain (score = 5)) at post-op compared with pre-op between the two treatment groups. Shapiro Wilk's test and Levene's test will be performed to check the normality and homogenous variance assumption of the two-sample t-test. Non-parametric approach (Mann-Whitney U-test) will be employed if there is significant violations of the normality assumption.
Day 1, Day 3 and Day 7 post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Victoria Yu, PhD, National University Hosptial, Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 13, 2018

Primary Completion (Actual)

June 30, 2019

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

November 1, 2018

First Submitted That Met QC Criteria

November 5, 2018

First Posted (Actual)

November 6, 2018

Study Record Updates

Last Update Posted (Actual)

July 14, 2023

Last Update Submitted That Met QC Criteria

July 13, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2018/00390

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Root Canal Obturation

Clinical Trials on TotalFill® Bioceramic sealer

3
Subscribe